By combining NUPR1 and TRIB3 with other clinical characteristics of DLBCL patients, such as gender, age, diagnosis type, stage, LDH ratio, number of extranodal lymph nodes, and ECOG score. Here, TRIB3 is linked to diffuse large B-cell lymphoma.